Safety and Antiviral Activity of Tmc435350 in Treatment-name Genotype 1 Hcv-infected Patients

Manns, Michael P.;Horsmans, Yves;Reesink, Hendrik W.;Moreno, Christophe;Verloes, Rene;et.al.
(2008) 59th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases — Location: San Francisco (Ca) (31.October.2008)

Files

No attached file found for this publication.

Details

Authors
  • Manns, Michael P.
    Author
  • Author
  • Reesink, Hendrik W.
    Author
  • Moreno, Christophe
    Author
  • Verloes, Rene
    Author
Show more
Affiliations

Citations

Manns, M. P., Horsmans, Y., Reesink, H. W., Moreno, C., Berg, T., Benhamou, Y., Dusheiko, G. M., Flisiak, R., Meyvisch, P., Lenz, O., Simmen, K., & Verloes, R. (2008). Safety and Antiviral Activity of Tmc435350 in Treatment-name Genotype 1 Hcv-infected Patients. Hepatology, 48(4), 1023A-1023A. https://doi.org/10.1002/hep.22502 (Original work published 2008)